Annovis Bio ANVS
NYSE ANVS
$1.32 -0.06 (-4.71%)
As of: Sep 29, 2026 · 3:59 PM EDT

Annovis Bio (ANVS) Receivables - Other (2019 - 2020)

Updated

Annovis Bio's Receivables - Other came in at $424,952 for Q3 2020, up 113.3% from the prior quarter.

Analysis

Annovis Bio (ANVS) Receivables - Other (2019 - 2020) Analysis & Trends

At the end of FY2019, Annovis Bio's Receivables - Other was $735,075.

  • The five-year range for quarterly Receivables - Other is $37,752 (Q1 2020) to $735,075 (Q4 2019).
  • Business Quant data shows ANVS's Receivables - Other at $199,221 (Q2 2020), $37,752 (Q1 2020) and $735,075 (Q4 2019) in the three quarters before Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Annovis Bio 58.80 Mn 58.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 424,952.00
Jun 30, 2020 199,221.00
Mar 31, 2020 37,752.00
Dec 31, 2019 735,075.00
API Access

Annovis Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANVS&period=max&api_key=YOUR_API_KEY